# Narration and storyboard draft: Shingles Vaccination and Dementia Prevention

Authored draft, approximately 60–90 seconds; no rendered video claimed.

Shingles vaccination may prevent or delay some dementia diagnoses. The strongest evidence compares nearly identical birth dates around a vaccine-eligibility cutoff, a stronger design than simply comparing vaccine users with nonusers. The Welsh experiment reports a local positive effect. Other countries also find fewer diagnoses, but eligibility and actual vaccination are different measurements, and a recent quantitative critique questions some implied effect sizes. Recombinant-vaccine cohorts are encouraging but still face treatment-selection and calendar-time bias. The cause of any protection also remains unresolved: preventing viral reactivation and broader immune effects could both contribute. Different dementia-prevention drugs have their own positive and null trials; they cannot be treated as a single proven class. Our next decisive work would validate individual uptake and causal magnitude and measure diagnosed dementia under credible independent assignment. The evidence does not yet establish universal protection or a necessary pathogen mechanism.

1. Show the exact claim, grade and confidence.
2. Show selected publication milestones; label experimental systems and clinical endpoints.
3. Contrast the strongest result with its source-specific limitation.
4. End with the boundary experiment and primary-source links.

Use authored schematics; do not depict Consensus meters as causal confidence or reproduce publisher graphics without appropriate permission.